PyInvesting

Market research

NZM2.F Novozymes A/S

F EUR Basic Materials

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
28B
P/E ratio
43.99
Analyst target
Not available
Dividend yield
1.5%
Beta
0.62

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Novozymes A/S is currently in a long term uptrend where the price is trading 19.0% above its 200 day moving average.

From a valuation standpoint, the stock is 96.7% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 8.2.

Novozymes A/S's total revenue sank by 7.6% to $3B since the same quarter in the previous year.

Its net income has dropped by 29.1% to $654M since the same quarter in the previous year.

Finally, its free cash flow grew by 399.3% to $754M since the same quarter in the previous year.

Based on the above factors, Novozymes A/S gets an overall score of 3/5.